HITS
Seoul
About HITS
HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm. The company creates a cloud-based drug development platform that connects AI models with docking and molecular dynamics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $4.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2022)
- Website: hits.ai
- Phone: +82-2-6953-0317
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/hits-16532 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.